<document xmlns="http://cnx.rice.edu/cnxml">
  <title>Androgens, Antiandrogens, and Anabolic Steroids</title>
  <metadata xmlns:md="http://cnx.rice.edu/mdml">
    <md:title>Androgens, Antiandrogens, and Anabolic Steroids</md:title>
    <md:content-id>m00452</md:content-id>
    <md:uuid>b3ea78fe-b25a-4f50-a136-3e4d285ecb51</md:uuid>
  </metadata>
  <content>
<section class="learning-objectives" id="sect-00001">
<title>Learning Outcomes</title>
<para id="para-00001">By the end of this section, you should be able to:</para>
<list list-type="bulleted" id="list-00001">
<item>Identify the characteristics of androgen, antiandrogen, and anabolic steroid drugs used to treat reproductive disorders.</item>
<item>Explain the indications, actions, adverse reactions, and interactions of androgen, antiandrogen, and anabolic steroid drugs used to treat reproductive disorders.</item>
<item>Describe nursing implications of androgen, antiandrogen, and anabolic steroid drugs used to treat reproductive disorders.</item>
<item>Explain the client education related to androgen, antiandrogen, and anabolic steroid drugs used to treat reproductive disorders.</item>
</list>
</section>
<para id="para-00002">Androgens, antiandrogens, and anabolic steroids drugs are natural and synthetic forms of testicular hormones. They are used to treat hypogonadism, delayed male puberty, and some types of female breast cancer. They can also be used off-label for stimulation of appetite and to increase muscle mass in malignancy and acquired immunodeficiency syndrome (AIDS) (Ganesan et al., 2023).</para>
<section id="sect-00003">
<title>Androgens</title>
<para id="para-00003">Androgens are sex hormones. Testosterone is the primary androgen and is produced in the testes. The other androgens are produced in the adrenal glands. Testosterone is responsible for the growth and development of male sex organs and the secondary sex characteristics such as voice deepening, hair distribution, and redistribution of muscle and fat. It also contributes to bone growth, red blood cell production, decreased excretion of calcium in the urine, and the retention of sodium, potassium, and phosphorous.</para>
<para id="para-00004"><term id="term-00001">Hypogonadism</term> is the condition where the testes are undeveloped and fail to produce androgen, sperm, or both. Males with hypogonadism do not experience puberty. <term id="term-00002">Delayed puberty</term> is when the male sex characteristics do not develop at the expected time in puberty. Clients experiencing either condition may need exogenous hormone therapy to develop normal male sex organs and secondary sex characteristics.</para>
<para id="para-00005">The prototype androgen is testosterone. It comes in oral, parenteral, topical, implantable, and buccal forms. Dosage and frequency vary depending on the form of the drug and the individual need of the client. <link target-id="table-00001" document="m00452"/> lists common <term class="no-emphasis" id="term-00003">androgens</term> and typical routes and dosing for adult clients.</para>
<table class="vertically-tight" id="table-00001">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="2*"/>
<thead>
<row>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Drug</span></emphasis></entry>
<entry valign="top" align="center"><emphasis effect="bold"><span class="blue-text">Routes and Dosage Ranges</span></emphasis></entry>
</row>
</thead>
<tbody>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00004">Testosterone</term><newline/>
(<term class="no-emphasis" id="term-00005">Depo-testosterone</term>, <term class="no-emphasis" id="term-00016">Androderm</term>)</entry>
<entry valign="top" align="left"><emphasis effect="italics">Male hypogonadism/delayed puberty:</emphasis><newline/>
<list list-type="bulleted" id="list-00002">
<item><emphasis effect="italics">Depo-testosterone:</emphasis> 50–400 mg intramuscularly every 2–4 weeks.</item>
<item><emphasis effect="italics">Androderm:</emphasis> 4 mg/day transdermal patch (adjusted per serum testosterone concentration).</item>
</list></entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00006">Fluoxymesterone</term><newline/>
(<term class="no-emphasis" id="term-00007">Halotestin</term>)</entry>
<entry valign="top" align="left"><emphasis effect="italics">Male hypogonadism/delayed puberty:</emphasis> 5–20 mg daily orally.<newline/>
<emphasis effect="italics">Breast cancer treatment in postmenopausal females:</emphasis> 10–40 mg/day orally.</entry>
</row>
<row>
<entry valign="middle" align="center"><term class="no-emphasis" id="term-00008">Methyltestosterone</term><newline/>
(<term class="no-emphasis" id="term-00009">Methitest</term>)</entry>
<entry valign="top" align="left"><emphasis effect="italics">Hypogonadism, delayed puberty in males:</emphasis> 10–50 mg daily orally.<newline/>
<emphasis effect="italics">Breast cancer treatment in postmenopausal females:</emphasis> 50–200 mg/day orally.</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Emphasis Table: Androgens</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
<section id="sect-00004">
<title>Adverse Effects and Contraindications</title>
<para id="para-00006">The adverse effects of testosterone for males include gynecomastia, prolonged penile erections, and decreased ejaculatory volume. For females taking testosterone for advanced breast cancer, side effects are generally related to masculinization—voice deepening, clitoral enlargement, and hirsutism. Menstrual irregularities and amenorrhea may develop in premenopausal clients.</para>
<para id="para-00007">Androgens are contraindicated in hypersensitivity to the drug, male breast and prostate cancer, and serious cardiac, hepatic, or renal disease. Additionally, testosterone must be used cautiously in prepubescent clients because of the possibility of early bone maturation and early closure of the epiphyseal growth plates. This condition can lead to stunted growth. When young clients are on testosterone therapy, they need radiographs every 6 months to monitor bone maturation.</para>
<para id="para-00008">Clients with preexisting gynecomastia may have a worsening of the condition. <term class="no-emphasis" id="term-00010">Older clients</term> may have an increased risk of benign prostatic hyperplasia (BPH) and prostate cancer. Clients with BPH may develop urethral obstruction. Testosterone is contraindicated for pregnant clients because it can cause masculinization of the female fetus, and the risks of the drug outweigh the potential benefits for pregnant clients. See <link document="m00443">Urinary and Bladder Disorder Drugs</link> for more about BPH and its treatment.</para>
<para id="para-00009"><link target-id="table-00002" document="m00452"/> is a drug prototype table for androgens featuring testosterone. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00002">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Androgen<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Binds to and activates androgen receptors</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
<emphasis effect="italics">Male hypogonadism/delayed puberty:</emphasis>
<list list-type="bulleted" id="list-00003">
<item><emphasis effect="italics">Depo-testosterone:</emphasis> 50–400 mg intramuscularly every 2–4 weeks.</item>
<item><emphasis effect="italics">Androderm:</emphasis> 4 mg/day transdermal patch (adjusted per serum testosterone concentration).</item>
</list>
</entry>
</row>
<row><entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
Replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Development of male sex characteristics
</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
Oral anticoagulants<newline/>
May decrease blood glucose levels in clients with diabetes, so hyperglycemic drug doses may need to be decreased<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions
</entry>
</row>
<row><entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Hypercalcemia in immobilized clients<newline/>
Gynecomastia<newline/>
Excessive frequency and duration of penile erections<newline/>
Hirsutism<newline/>
Male pattern baldness<newline/>
Seborrhea<newline/>
Acne<newline/>
Nausea<newline/>
Cholestatic jaundice<newline/>
Alterations in liver function tests<newline/>
Venous thromboembolism<newline/>
Increased or decreased libido<newline/>
Headache<newline/>
Anxiety<newline/>
Depression</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Known hypersensitivity to the drug<newline/>
Male breast cancer<newline/>
Prostate cancer<newline/>
Pregnancy<newline/>
Serious cardiac, hepatic, or renal disease<newline count="2"/>
Caution:<newline/>
Benign prostatic hyperplasia</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Testosterone</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00005">
<title>Antiandrogens</title>
<para id="para-00010"><term id="term-00011">Antiandrogens</term> are medications that compete with testosterone for androgen-receptor binding sites; in other words, they work against androgens and testosterone. Antiandrogens either prevent these hormones from binding to proteins in the target cells or decrease the amount of a hormone produced. Antiandrogens are used to treat advanced prostate cancer. Bicalutamide is the primary medication used. It should be taken in combination with a gonadotropin-releasing hormone analog to treat metastatic prostate cancer.</para>
<para id="para-00011">Antiandrogens are frequently used in combination with gonadotropin-releasing hormone analogs to treat advanced prostate cancer (Freedland &amp; Abrahamsson, 2021). These two groups of medications have different mechanisms of action, but both decrease testosterone to nonexistent levels comparable to surgical castration.</para>
</section>
<section id="sect-00006">
<title>Adverse Effects and Contraindications</title>
<para id="para-00012">Contraindications for the use of antiandrogens are allergy to the drug or its components and liver dysfunction or elevated liver enzymes. The adverse effects of antiandrogens include gynecomastia, breast pain, hot flashes, decreased libido, impotence, diarrhea, anemia, and abnormal liver function. Liver failure can occur.</para>
<para id="para-00013"><link target-id="table-00003" document="m00452"/> is a drug prototype table for antiandrogens featuring <term class="no-emphasis" id="term-00012">bicalutamide</term>. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00003">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Antiandrogen<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Inhibits the action of androgens by binding to cytosol androgen receptors in the target tissue</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
50 mg orally daily (along with a luteinizing hormone–releasing hormone [LHRH] analog).</entry>
</row>
<row><entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
Treatment of stage D2 metastatic carcinoma of the prostate<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Stops the growth and spread of cancer cells
</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
Coumadin<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions</entry></row>
<row><entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Pain (general)<newline/>
Back pain<newline/>
Asthenia<newline/>
Pelvic pain<newline/>
Infection<newline/>
Abdominal pain<newline/>
Chest pain<newline/>
Headache<newline/>
Flu syndrome<newline/>
Hot flashes<newline/>
Nausea<newline/>
Leg cramps<newline/>
Hypercholesteremia<newline/>
Elevated liver enzymes<newline/>
Gynecomastia</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Known hypersensitivity to the drug or its components<newline/>
Use in female clients<newline/>
Pregnancy</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Bicalutamide</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
</section>
<section id="sect-00007">
<title>Anabolic Steroids</title>
<para id="para-00014"><term id="term-00013">Anabolic steroids</term> are analogues of testosterone developed for use in tissue building in conditions such as illness or surgery that have caused significant wasting of tissue, weight loss, and depletion of red blood cells. Oxandrolone is the primary anabolic steroid. It is indicated for weight gain and cancer treatment. The dosage for oxandrolone is 2.5 mg–20 mg, two to four times daily, administered orally.</para>
<para id="para-00015">Both androgens and anabolic steroids stimulate protein synthesis in skeletal muscle and thus increase the buildup of cellular tissue. They also stimulate increased production of red blood cells. For those reasons, androgens and anabolic steroids are used in clients who are debilitated by chronic illnesses (e.g., cancer, HIV, anemias), trauma, long-term steroid use, or surgery in order to increase muscle mass, gain weight, repair tissue, and increase red blood cell count (Ganesan et al., 2023).</para>
</section>
<section id="sect-00008">
<title>Adverse Effects and Contraindications</title>
<para id="para-00016">In general, anabolic steroids can cause electrolyte imbalances, liver damage, insomnia, weight gain, acne, depression, anxiety, aggression, increased cholesterol and low-density lipoprotein levels, hypertension, and changes in the structure of the left ventricle of the heart (DailyMed, <emphasis effect="italics">Oxandrolone tablet</emphasis>, 2022).</para>
<para id="para-00017">The adverse effects in prepubertal clients include phallic enlargement, hirsutism, and increased skin pigmentation. In postpubertal clients, side effects can include decreased testicular function and testicular atrophy, gynecomastia, priapism, baldness, and changes in libido. Prostate problems, especially in <term class="no-emphasis" id="term-00014">older clients</term>, may also be a side effect of these drugs. Female clients may experience hirsutism, voice deepening, clitoral enlargement, baldness, reduced breast volume, and menstrual irregularities (DailyMed, <emphasis effect="italics">Oxandrolone tablet</emphasis>, 2022).</para>
<para id="para-00018">These medications are contraindicated in allergy to the drug, pregnancy and lactation, liver or coronary heart disease, nephrosis, hypercalcemia, and breast or prostate cancer in males (DailyMed, <emphasis effect="italics">Oxandrolone tablet,</emphasis> 2022).</para>
<para id="para-00019">All anabolic steroids are DEA Schedule III drugs; however, anabolic steroids and testosterone have been misused by many athletes, both professional and amateur, for the purposes of bodybuilding and enhancing physical performance in sports (Chegeni et al., 2021; Ganesan et al., 2023; Schneider et al., 2020). These drugs are not approved to be used for bodybuilding or enhancing physical performance and, thus, are not prescribed by health care professionals for those purposes, nor are they permitted by athletic competition boards.</para>
<para id="para-00020"><link target-id="table-00004" document="m00452"/> is a drug prototype table for anabolic steroids featuring <term class="no-emphasis" id="term-00015">oxandrolone</term>. It lists drug class, mechanism of action, adult dosage, indications, therapeutic effects, drug and food interactions, adverse effects, and contraindications.</para>
<table class="vertically-tight" id="table-00004">
<tgroup cols="2">
<colspec colnum="1" colname="c1" colwidth="1*"/>
<colspec colnum="2" colname="c2" colwidth="1*"/>
<tbody>
<row>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Class</emphasis></span><newline/>
Anabolic steroid<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Mechanism of Action</emphasis></span><newline/>
Inhibits the action of androgens by binding to cytosol androgen receptors in the target tissue</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Drug Dosage</emphasis></span><newline/>
2.5–20 mg orally given in 2–4 divided doses.</entry>
</row>
<row><entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Indications</span></emphasis><newline/>
Adjunctive therapy to offset the protein catabolism associated with prolonged administration of corticosteroids<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Therapeutic Effects</emphasis></span><newline/>
Relief of the bone pain frequently accompanying osteoporosis<newline/>
Weight gain and muscle building</entry>
<entry valign="top" align="left"><emphasis effect="bold"><span class="blue-text">Drug Interactions</span></emphasis><newline/>
Coumadin<newline/>
Oral hypoglycemic medications<newline/>
Adrenal steroids or adrenocorticotropic hormone (ACTH)<newline count="2"/>
<span class="blue-text"><emphasis effect="bold">Food Interactions</emphasis></span><newline/>
No significant interactions</entry></row>
<row><entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Adverse Effects</emphasis></span><newline/>
Cholestatic jaundice<newline/>
Habituation<newline/>
Excitation<newline/>
Insomnia<newline/>
Depression<newline/>
Changes in libido<newline/>
Edema<newline/>
Retention of serum electrolytes (sodium chloride, potassium, phosphate, calcium)<newline/>
Decreased glucose tolerance<newline/>
Increased creatinine excretion<newline/>
Increased serum creatinine phosphokinase (CPK)<newline/>
Inhibition of gonadotropin secretion<newline/>
Hepatic necrosis and death (rare)<newline/>
<emphasis effect="italics">In Prepubertal Males:</emphasis><newline/>
Phallic enlargement and increased frequency or persistence of erections<newline/>
<emphasis effect="italics">In Postpubertal Males:</emphasis><newline/>
Inhibition of testicular function<newline/>
Testicular atrophy<newline/>
Oligospermia<newline/>
Impotence<newline/>
Chronic priapism<newline/>
Epididymitis<newline/>
Bladder irritability<newline/>
Gynecomastia<newline/>
<emphasis effect="italics">In Females:</emphasis><newline/>
Clitoral enlargement<newline/>
Menstrual irregularities<newline/>
Deepening of the voice<newline/>
Hirsutism and male pattern baldness<newline/>
Masculinization of the fetus</entry>
<entry valign="top" align="left"><span class="blue-text"><emphasis effect="bold">Contraindications</emphasis></span><newline/>
Known hypersensitivity to the drug or its components<newline/>
Use in female clients<newline/>
Pregnancy<newline/>
Known or suspected prostate or male breast cancer<newline/>
Female breast cancer with hypercalcemia<newline/>
Nephrosis<newline/>
Hypercalcemia<newline count="2"/>
Caution:<newline/>
Clients with moderate to severe chronic obstructive pulmonary disease (COPD) and who are unresponsive to bronchodilators should be monitored closely for COPD exacerbation and fluid retention</entry>
</row>
</tbody>
</tgroup>
<caption><emphasis effect="bold">Drug Prototype Table: Oxandrolone</emphasis> (source: https://dailymed.nlm.nih.gov/dailymed/)</caption>
</table>
<note class="black-box" id="note-00001">
<para id="para-00021"><emphasis effect="bold">Oxandrolone</emphasis></para>
<para id="para-00022">Oxandrolone can cause serious liver problems, including hepatitis and tumors, and serum lipid changes that could cause coronary heart disease.</para>
<para id="para-00023">Oxandrolone may accelerate bone maturation without producing compensatory gain in linear growth, a condition called premature closure of epiphyses in children. This adverse effect results in compromised adult height.</para>
</note>
</section>
<section id="sect-00009">
<title>Nursing Implications</title>
<para id="para-00024">The nurse should do the following for clients who are taking androgens, antiandrogens, anabolic steroids, or GnRH analogues:</para>
<list list-type="bulleted" id="list-00004">
<item> Determine the reason for use of androgens, antiandrogens, anabolic steroids, or GnRH analogues.</item>
<item>Assess understanding of indication for specific drug therapy and ability to comprehend instructions.</item>
<item>Perform gender- and age-appropriate physical assessment, including height, weight, and blood pressure.</item>
<item>Assess past medical history and family history for cardiovascular disease (heart attack, stroke, hypertension), pregnancy/lactation status, breast or prostate cancer, gynecomastia, and BPH.</item>
<item>Obtain medication list including OTC and herbal remedies.</item>
<item>Assess smoking history and use of alcohol.</item>
<item>Obtain pertinent diagnostic testing such as long bone radiographs and laboratory studies for liver and renal function, complete blood count, serum chemistries, and lipids, and monitor as necessary.</item>
<item>Assess ability to administer drug at home and follow medication regimen.</item>
<item>Monitor for any misuse of drug therapy.</item>
<item>Provide client teaching regarding the drug and when to call the health care provider. See below for client teaching guidelines.</item>
</list>
<note class="client-teaching" id="note-00002">
<para id="para-00025"><emphasis effect="bold">The client taking an androgen, antiandrogen, anabolic steroid, or GnRH analogue should:</emphasis></para>
<list list-type="bulleted" id="list-00005">
<item>Understand the medication’s purpose, side effects, contraindications, and precautions.</item>
<item>Understand the medication dosage and route and be able to self-administer correctly (oral, patch, injections).</item>
<item>Monitor any signs and symptoms of adverse effects and report those that require immediate attention.</item>
<item>Monitor and record pertinent observations such as weight, height, and blood pressure as instructed.</item>
<item>Monitor and report emotional and/or behavioral changes to health care provider.</item>
<item>Know how to manage the side effects of various hormonal medications.</item>
<item>Understand drug, food, and/or herbal interactions that could be harmful. See drug prototype tables for specific drugs.</item>
<item>Verbalize the importance of follow-up appointments to manage the medication regimen and to observe for adverse effects.</item>
</list>
<para id="para-00026"><emphasis effect="bold">The client taking an androgen, antiandrogen, anabolic steroid, or GnRH analogue <emphasis effect="italics">should not:</emphasis></emphasis></para>
<list list-type="bulleted" id="list-00006">
<item>Alter the dosage or abruptly discontinue these medications.</item>
<item>Smoke or consume alcohol.</item>
</list>
</note>
</section>
</section>
</content>
<glossary>
<definition id="def-00001"><term>anabolic steroids</term> <meaning>a category of medications, analogues to testosterone, used to enhance tissue building and stimulate production of red blood cells</meaning></definition>
<definition id="def-00002"><term>antiandrogens</term> <meaning>medications that compete with testosterone for androgen-receptor binding sites and work against androgens and testosterone</meaning></definition>
<definition id="def-00003"><term>delayed puberty</term> <meaning>condition when the male sex characteristics do not develop at the expected time in puberty</meaning></definition>
<definition id="def-00004"><term>hypogonadism</term> <meaning>condition in which testes are undeveloped and the development of sex organs and secondary sex characteristics is delayed or absent</meaning></definition>
</glossary>
</document>